KBI Biopharma
.png?width=650&height=257&name=PEGS%20Boston%20Web%20Banner%20(1).png)
Séverine Fagète
VP, Cell Line Services
Join KBI Biopharma at PEGS Boston
When: May 12-16, 2025
Where: Boston, Massachusetts
KBI Biopharma is headed to Massachusetts for PEGS Boston this May!
Schedule a meeting >>
Meet with the KBI Biopharma Team:
Leslie Wolfe
VP, Process Development & Site Head
Henry Jin
Senior Director, Business Development
Kierra Banks
Director, Business Development
Andrea Mislak
Director, AFS
FEATURED PRESENTATION:
Friday, May 16 at 10:00 AM ET
Séverine Fagète, Vice President, PhD, Mammalian Cell Line Development, CLD, KBI
The successful development of biotherapeutic molecules begins with the generation of a robust cell line. Choosing the right Cell Line Development (CLD) path is essential and should be focused on both comprehensive analysis of protein-to-be-expressed attributes and specific programs needs assessment. We have developed a robust transposase-based expression platform that overcomes these challenges and deliver consistent high-expressing cell lines up to 12g/L with sustained stability over 60 generations. To reach this goal, we have leveraged a proprietary CHO-M mammalian cell to design comprehensive CLD workflows without compromising the successful inherited assets from our former random expression platform. In this “trust our experts” approach, we offer flexible solutions and risk mitigation strategies to ensure the best cell line development path for any therapeutic protein format.
About KBI Biopharma:
KBI Biopharma is a leading global contract development and manufacturing organization (CDMO) providing fully integrated, accelerated drug development and biologics manufacturing services and expertise to life science companies. With each of our 500+ client partners, we work closely to personalize and accelerate drug development programs. Built upon a foundation of world-class analytics capabilities and extensive scientific and technical expertise, we deliver robust process development and clinical and commercial cGMP manufacturing services for mammalian and microbial programs. Recognized for quality manufacturing, we help clients advance drug candidates into the clinic and beyond.
Learn more about KBI Biopharma >>
About the Event:
The 2025 PEGS Boston Summit is set to build on the remarkable success of previous years, continuing its legacy as the premier event for biologics and protein engineering. Bringing together a global community of experts, innovators, and leaders in the field, the Summit will offer cutting-edge insights into the latest advances in drug development, protein and antibody engineering, immunotherapy, radiotherapy, and AI/ML-driven biologics research. With over 300 presentations, breakout sessions, and interactive seminars, attendees will have unparalleled opportunities to network, learn, and engage in meaningful collaborations.
June 2025: BIO International
Join KBI Biopharma at BIO International 2025 Booth # 2065 When: June 16-19, 2025 Where: Boston, Massachusetts KBI Biopharma is headed to Boston for...
May 2025: PEGS Boston
Join KBI Biopharma at PEGS Boston When: May 12-16, 2025 Where: Boston, Massachusetts KBI Biopharma is headed to Massachusetts for PEGS Boston this...
May 2025: BIO KOREA
Join KBI Biopharma at BIO KOREA Booth # N28 When: May 7-9, 2025 Where: Seoul, Korea KBI Biopharma is headed to Seoul for BIO KOREA this May!Schedule...